Ligand validation:6FAL

IOP: INDOLYLPROPIONIC ACID

IOP is a Ligand Of Interest in 6FAL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6FAL_IOP_A_201	84%	44%	0.092	0.953	1.07	1.09	2	1	0	0	100%	1
6FAL_IOP_B_201	69%	39%	0.119	0.933	1.37	1.03	2	-	0	0	100%	1
6F7F_IOP_D_201	87%	48%	0.099	0.973	1.14	0.88	1	-	0	0	100%	1
7KH3_IOP_A_201	88%	41%	0.086	0.963	1.06	1.21	-	2	0	0	100%	0.572
4EJL_IOP_A_106	67%	40%	0.154	0.964	1	1.34	-	2	0	0	100%	1
4EJK_IOP_A_101	60%	30%	0.089	0.874	0.92	1.86	-	5	0	0	100%	1
6QMG_IOP_A_201	22%	51%	0.27	0.891	1.03	0.88	1	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.